WORLD
Novavax reported late-stage data from its U.S.-based clinical trial showing its vaccine is ... - Latest Tweet by Reuters
The latest Tweet by Reuters states, 'Novavax reported late-stage data from its U.S.-based clinical trial showing its vaccine is more than 90% effective against COVID-19 across a variety of variants of the virus ...'
Novavax reported late-stage data from its U.S.-based clinical trial showing its vaccine is more than 90% effective against COVID-19 across a variety of variants of the virus https://t.co/CSVLLXhbLc pic.twitter.com/hXQVtpBzaP— Reuters (@Reuters) June 14, 2021
(The above story first appeared on LatestLY on Jun 14, 2021 06:46 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
